Live Breaking News & Updates on Tol Trimborn

Stay updated with breaking news from Tol trimborn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

Region Flamande , United States , United Kingdom , Great Britain , Paul Stoffels , Van Gijsel , Sandra Cauwenberghs , Marieke Vermeersch , John Mellors , Exchange Commission , European Parliament , Chronic Lymphocytic Leukemia , Two Phase , Tol Trimborn , Investor Relations , Corporate Communication , Globe Newswire ,

Galapagos NV: Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

Potential for paradigm shift in CAR-T therapy with CellPoint's decentralized point-of-care manufacturing model, in partnership with Lonza, and AboundBio's cutting-edge fully human antibody-based ....

Region Flamande , United States , United Kingdom , Great Britain , Paul Stoffels , Van Gijsel , Sandra Cauwenberghs , Marieke Vermeersch , John Mellors , Exchange Commission , European Parliament , Chronic Lymphocytic Leukemia , Two Phase , Tol Trimborn ,

Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

Region Flamande , United States , United Kingdom , Great Britain , Paul Stoffels , Van Gijsel , Sandra Cauwenberghs , Marieke Vermeersch , John Mellors , Exchange Commission , European Parliament , Chronic Lymphocytic Leukemia , Two Phase , Tol Trimborn , Investor Relations , Corporate Communication , Globe Newswire ,

Galapagos to acquire CellPoint and AboundBio to accelerate

Potential for paradigm shift in CAR-T therapy with CellPoint’s decentralized point-of-care manufacturing model, in partnership with Lonza, and AboundBio’s. ....

Region Flamande , United States , United Kingdom , Great Britain , Paul Stoffels , Van Gijsel , Sandra Cauwenberghs , Marieke Vermeersch , John Mellors , Exchange Commission , European Parliament , Chronic Lymphocytic Leukemia , Two Phase , Tol Trimborn , Brussels Stock Exchange Glpg , Galapagos Nv ,

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

Investegate announcements from Galapagos NV, Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies ....

Region Flamande , United States , United Kingdom , Great Britain , Paul Stoffels , Van Gijsel , Sandra Cauwenberghs , Marieke Vermeersch , John Mellors , Exchange Commission , European Parliament , Chronic Lymphocytic Leukemia , Two Phase , Tol Trimborn , Investegate Announcements , Investegate Company Announcements , Galapagos Nv , Lobenewswire And Globenewswire ,